Conditioning with targeted busulfan for autologous peripheral blood stem cells transplantation for acute myelogenous leukemia in an XYY male

Eriko Sada, Hideho Henzan, Ryoko Ohtani, Ken Takase, Toshihiro Miyamoto, Takahiro Fukuda, Koji Nagafuji, Keita Yamauchi, Yasushi Takamatsu, Shoichi Inaba, Mine Harada

研究成果: ジャーナルへの寄稿記事

1 引用 (Scopus)

抜粋

We report herein a 19-year-old Japanese male with XYY syndrome who developed acute myelogenous leukemia. During three courses of cytotoxic chemotherapy, he suffered repeated hepatic and renal insufficiencies, possibly related to latent dysfunction from the XYY syndrome. The patient was treated with granulocyte colony-stimulating factor combined with etoposide, cytarabine, and busulfan (the latter adjusted to a targeting dose) followed by autologous peripheral blood stem cell transplantation. He had no severe regimen-related toxicities and is now free of leukemia.

元の言語英語
ページ(範囲)55-58
ページ数4
ジャーナルAmerican Journal of Hematology
78
発行部数1
DOI
出版物ステータス出版済み - 1 1 2005

    フィンガープリント

All Science Journal Classification (ASJC) codes

  • Hematology

これを引用